Literature DB >> 3553480

Effects of oral calcium carbonate on blood pressure in subjects with mildly elevated arterial pressure.

R L Bloomfield, L D Young, G Zurek, J H Felts, M K Straw.   

Abstract

Recent investigations suggest that calcium supplementation may cause a lower arterial pressure in hypertensive individuals. We studied 32 patients with mildly elevated arterial pressure (diastolic pressure 88-95 mmHg) and inadequate dietary calcium intake (less than 750 mm/day), who were randomly assigned to placebo or 1500 mg/day elemental calcium for 4 weeks. Baseline and post-treatment urinary calcium concentrations and 3 biweekly supine blood pressures were recorded. Supine systolic blood pressure in the calcium group rose during the first 2 weeks of treatment (delta systolic blood pressure +5.9 mmHg; P less than 0.025) compared with no change in supine blood pressure for the placebo group. Within the calcium group, seven out of 15 patients had decreased or unchanged supine blood pressure during treatment. A lower urinary calcium concentration and a lower dietary sodium intake were found in this subgroup compared with those whose supine blood pressure increased with calcium administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3553480

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

Review 1.  The role of calcium supplementation in the treatment of hypertension. Current evidence.

Authors:  D E Grobbee; H J Waal-Manning
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

Review 2.  Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.

Authors:  A Chockalingam; D Abbott; M Bass; R Battista; R Cameron; J de Champlain; C E Evans; J Laidlaw; B L Lee; L Leiter
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 3.  Calcium and blood pressure.

Authors:  N M Kaplan
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.